![Andrew John Matthew Clark](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew John Matthew Clark
Presidente en vasopharm GmbH .
Fortuna: 235 507 $ al 31/05/2024
Perfil
Andrew John Matthew Clark was the founder of Reabourne Ltd., which was founded in 1995 where he held the title of Portfolio Manager from 1995 to 2003.
He is currently the Chairman-Supervisory Board at vasopharm GmbH.
Dr. Clark's former positions include Director at Liminal BioSciences, Inc., Senior Independent Non-Executive Director at Lifeline Scientific, Inc., and Director at Hologic Ltd.
Dr. Clark received a doctorate degree from the University of St. Andrews.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
01/05/2023 | 3 066 502 ( 1.08% ) | 235 507 $ | 31/05/2024 |
Cargos activos de Andrew John Matthew Clark
Empresas | Cargo | Inicio |
---|---|---|
vasopharm GmbH
![]() vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Presidente | - |
Antiguos cargos conocidos de Andrew John Matthew Clark.
Empresas | Cargo | Fin |
---|---|---|
Reabourne Ltd. | Fundador | 01/01/2003 |
LIMINAL BIOSCIENCES INC. | Director/Miembro de la Junta | - |
LIFELINE SCIENTIFIC, INC | Director/Miembro de la Junta | - |
Hologic Ltd.
![]() Hologic Ltd. Medical SpecialtiesHealth Technology Hologic Ltd. manufactures life sciences products and services with two divisions, Molecular Diagnostics and Research Products & Services. The firm has laboratories, manufacturing and operations in the USA, UK and France. It provides test kits, reagents and services to two synergistic markets. It focuses on these niche opportunities with products, patents, expertise and acquisitions. The company was founded in 1992 and is headquartered in Wythenshawe, the United Kingdom. | Director/Miembro de la Junta | - |
Formación de Andrew John Matthew Clark.
University of St. Andrews | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
LIMINAL BIOSCIENCES INC. | Health Technology |
Empresas privadas | 4 |
---|---|
Reabourne Ltd. | |
Hologic Ltd.
![]() Hologic Ltd. Medical SpecialtiesHealth Technology Hologic Ltd. manufactures life sciences products and services with two divisions, Molecular Diagnostics and Research Products & Services. The firm has laboratories, manufacturing and operations in the USA, UK and France. It provides test kits, reagents and services to two synergistic markets. It focuses on these niche opportunities with products, patents, expertise and acquisitions. The company was founded in 1992 and is headquartered in Wythenshawe, the United Kingdom. | Health Technology |
vasopharm GmbH
![]() vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Health Technology |
Lifeline Scientific, Inc.
![]() Lifeline Scientific, Inc. Medical SpecialtiesHealth Technology Lifeline Scientific, Inc. engages in the development and marketing of advanced medical products and services. It focuses on tissue testing technologies. It also intends to provide more and better quality organs, tissues and cells, in support of transplant professionals worldwide, and the life-saving services. The company was founded by David Kravitz on October 1, 1998 and is headquartered in Itasca, IL. | Health Technology |
- Bolsa de valores
- Insiders
- Andrew John Matthew Clark